Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Department of Biomedical Sciences, School of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
Cell Prolif. 2021 Feb;54(2):e12913. doi: 10.1111/cpr.12913. Epub 2020 Dec 17.
MicroRNAs (miRNAs) are small and highly conserved non-coding RNAs that silence target mRNAs, and compelling evidence suggests that they play an essential role in the pathogenesis of human diseases, especially cancer. miR-125b, which is the mammalian orthologue of the first discovered miRNA lin-4 in Caenorhabditis elegans, is one of the most important miRNAs that regulate various physiological and pathological processes. The role of miR-125b in many types of cancer has been well established, and so here we review the current knowledge of how miR-125b is deregulated in different types of cancer; its oncogenic and/or tumour-suppressive roles in tumourigenesis and cancer progression; and its regulation with regard to treatment response, all of which are underlined in multiple studies. The emerging information that elucidates the essential functions of miR-125b might help support its potentiality as a diagnostic and prognostic biomarker as well as an effective therapeutic tool against cancer.
微小 RNA(miRNAs)是一类小而高度保守的非编码 RNA,可以沉默靶 mRNA,有充分的证据表明它们在人类疾病的发病机制中,尤其是癌症中发挥着重要作用。miR-125b 是哺乳动物对线虫中第一个发现的 miRNA lin-4 的同源物,是调节各种生理和病理过程的最重要的 miRNA 之一。miR-125b 在多种类型的癌症中的作用已得到充分证实,因此,在这里我们回顾了目前关于 miR-125b 在不同类型的癌症中如何失调的知识;它在肿瘤发生和癌症进展中的致癌和/或肿瘤抑制作用;以及它在治疗反应方面的调控,这些在多项研究中都有强调。阐明 miR-125b 基本功能的新信息可能有助于支持其作为诊断和预后生物标志物以及对抗癌症的有效治疗工具的潜力。